Abstract
Although there are many approaches to the treatment of postherpetic neuralgia (PHN),1–4 many patients do not respond or derive only partial benefit. The development of more effective and better tolerated treatments for PHN is therefore an important goal for future research. A method for preventing PHN would not only make the development of such treatments unnecessary but also eliminate the disability, psychological distress, and use of health-care resources due to PHN.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
